Key Takeaways
- PMOS (Polyendocrine Metabolic Ovarian Syndrome) is the new official name for PCOS, reflecting its true nature as a hormonal and metabolic condition
- The condition affects approximately one in eight women worldwide and nearly 20% of Indian women
- Common symptoms include irregular periods, excess hair growth, acne, and ovulatory problems
- Insulin resistance plays a central role in PMOS and can create a self-perpetuating cycle with excess androgens
- PMOS is a leading cause of infertility and may increase pregnancy complication risks
- Diagnosis requires professional evaluation using specific criteria
- Management includes lifestyle modifications and medications tailored to individual symptoms
- PMOS is a lifelong condition that requires ongoing management but can be effectively controlled
If you have been following recent health news, you may have come across the term 'PMOS' and wondered what it means. The PMOS full form is polyendocrine metabolic ovarian syndrome, which is the new official name for the condition polycystic ovary syndrome (PCOS). This renaming, announced in 2026, affects approximately one in eight women worldwide [1].
The change aims to better reflect the condition's true nature as a hormonal and metabolic disorder rather than simply an ovarian problem. This guide will help you understand what PMOS is, its symptoms, causes, and how to manage it effectively.
What is PMOS?
Understanding what PMOS is begins with recognising it as a common hormonal disorder characterised by fluctuations in hormone levels that can affect multiple body systems. The condition involves higher than normal androgen levels, which may lead to irregular menstrual periods, abnormal ovulation, infertility, excess facial or body hair, and acne [2].
The meaning of PMOS extends beyond reproductive health. This condition can impact weight, metabolic health, mental wellbeing, and skin. PMOS affects an estimated 10 to 13% of reproductive-aged women globally [2], with prevalence in India reaching approximately 19.6% according to national studies [3].
What are the common signs and symptoms of PMOS?
Women with PMOS may experience a range of symptoms that can vary in severity from person to person. Common signs include [2]:
- Irregular or infrequent menstrual periods
- Pain accompanied by heavy menstrual bleeding
- Excessive facial or body hair growth (hirsutism)
- Female-pattern baldness or hair thinning
- Oilier skin and persistent acne
- Small, fluid-filled follicles on the ovaries (not true cysts) visible on ultrasound
Not every woman with PMOS will experience all these symptoms. The presentation can vary significantly, which is why professional diagnosis is essential. Consult your doctor if these symptoms persist.
What causes PMOS?
The exact cause of PMOS remains under investigation, but several interconnected factors contribute to its development.
Insulin resistance plays a central role. Research indicates that insulin resistance and compensatory hyperinsulinemia (elevated insulin levels) are present in 65 to 95% of women with PMOS. This includes the majority of overweight women with the condition and more than half of women at normal weight [4].
When insulin resistance occurs, elevated insulin levels work together with luteinising hormone (LH) to promote ovarian steroidogenesis and suppress hepatic production of sex hormone-binding globulin (SHBG). This process can worsen hyperandrogenaemia (excess androgens). Simultaneously, androgens can further aggravate insulin resistance, creating a self-perpetuating cycle [5].
Is PMOS a new condition or just a new name for PCOS?
PMOS is not a new condition. It is simply the updated name for the same condition previously known as PCOS. The renaming process was an extensive disease-renaming initiative, involving input from over 14,360 survey responses from 56 global organisations [1].
The change was necessary because the term "PCOS" was considered inaccurate. The old name implied that pathological ovarian cysts were the primary feature, obscuring the condition's diverse endocrine and metabolic characteristics. This misnaming contributed to delayed diagnosis, fragmented care, and stigma [1].
By calling it polyendocrine metabolic ovarian syndrome, healthcare providers can better communicate that this is a complex hormonal and metabolic condition affecting multiple body systems, not merely an ovarian disease.
Can PMOS affect fertility and pregnancy?
Yes, PMOS can significantly impact fertility and pregnancy outcomes. The condition is the most common cause of anovulation (failure to release eggs) among women globally and a leading cause of infertility [2].
Women with PMOS who do conceive may face higher pregnancy-related risks. Research shows that the odds of miscarriage, gestational diabetes mellitus, gestational hypertension, pre-eclampsia, and caesarean section are higher in women with PMOS. These increased odds appear to be largely independent of age and body mass index [6].
Consult a healthcare provider for personalised guidance on conception and pregnancy planning.
How is PMOS diagnosed?
Diagnosis of PMOS in adults typically follows the Rotterdam criteria, which require two out of three features to be present [7]:
- Ovulatory dysfunction (irregular or absent ovulation)
- Clinical or biochemical hyperandrogenism (signs of excess androgens)
- Polycystic ovary morphology on ultrasound
For adolescents, the diagnostic approach differs. Both hyperandrogenism and ovulatory dysfunction must be present for a diagnosis. Ultrasound and anti-Müllerian hormone (AMH) testing are not recommended in this age group because they have low specificity [8].
Your doctor may also conduct blood tests to measure hormone levels, glucose tolerance, and lipid profiles to assess metabolic health.
How is PMOS managed?
Management of PMOS focuses on addressing symptoms, reducing long-term health risks, and supporting overall wellbeing. Lifestyle modifications remain vital throughout the lifespan for women with PMOS. These include maintaining a healthy diet, engaging in regular physical activity, and managing weight [9].
Pharmacological treatment depends on the specific symptoms and goals [9]:
- Combined oral contraceptive pills are considered first-line pharmacological treatment for menstrual irregularity and hyperandrogenism
- Metformin is recommended primarily for metabolic features and has demonstrated greater efficacy than inositol supplements
A healthcare provider must determine treatment based on your individual needs.
Read about - Best Diet & Foods for PCOS or PMOS Weight Loss
Can PMOS be controlled long-term?
PMOS is a chronic metabolic condition that persists beyond the reproductive years. While it cannot be cured, it can be effectively managed with appropriate care [2].
A lifelong health plan is recommended, including a focus on healthy lifestyle habits, preventing excess weight gain, optimising fertility when desired, and preventing and treating diverse clinical features [9]. With consistent management, many women with PMOS lead healthy, fulfilling lives.
Among Indian women with PMOS, studies have found that 43.2% have obesity, 91.9% have dyslipidaemia, and 24.9% have metabolic syndrome [3]. These findings highlight the importance of comprehensive, long-term metabolic monitoring.
When should you see a doctor?
It is estimated that up to 70% of women with PMOS worldwide remain undiagnosed [1]. This means many women experience symptoms without understanding the underlying cause.
You should consult a healthcare provider if you experience [9]:
- Irregular or missed periods for several consecutive cycles
- Unusual hair growth on face, chest, or back
- Persistent acne that does not respond to standard treatments
- Unexplained weight gain, particularly around the abdomen
- Signs of insulin resistance such as darkened skin patches
Early diagnosis can help prevent complications and improve quality of life.
FAQs
Can PMOS occur even if periods are regular?
Yes, PMOS can occur even with regular menstrual cycles. Ovulatory dysfunction may still be present despite seemingly normal periods. If your doctor needs to confirm the diagnosis, they may measure serum progesterone levels to check whether ovulation is actually occurring.
Is PMOS common in teenagers and young women?
Yes, PMOS can affect teenagers and young women. However, diagnosis in adolescents requires both hyperandrogenism and ovulatory dysfunction to be present. Ultrasound is not typically used for diagnosis in this age group due to low specificity.
Can stress worsen PMOS symptoms?
Chronic stress may worsen PMOS symptoms by affecting hormone balance. Stress can increase cortisol levels, which may influence androgen levels, insulin sensitivity, and menstrual regularity. Stress management techniques may help support overall symptom control.
Does every woman with PMOS gain weight?
No, not every woman with PMOS experiences weight gain. Insulin resistance affects the majority of women with PMOS, including more than half of those at normal weight. PMOS can occur across all body types and weight ranges.
Can PMOS symptoms improve with lifestyle changes?
Yes, lifestyle modifications can significantly improve PMOS symptoms. Healthy eating, regular physical activity, and weight management are recommended throughout life for overall health, metabolic improvement, and symptom control in women with PMOS.
Do all women with PMOS need medication?
No, not all women with PMOS require medication. Treatment decisions depend on individual symptoms, goals, and health status. Some women manage well with lifestyle changes alone, while others may benefit from medications targeting specific symptoms like irregular periods or metabolic features.
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. The information provided should not be used for diagnosing or treating health conditions. Always consult a qualified healthcare provider for diagnosis, treatment, and personalised medical advice. Do not disregard professional medical advice or delay seeking it because of information found in this article. If you have a medical emergency, contact your doctor or emergency services immediately.
References
Teede, H. J., Khomami, M. B., Morman, R., Laven, J. S. E., Joham, A. E., Costello, M. F., Patil, M., Rees, D. A., Berry, L., Cree, M. G., Zhao, H., Norman, R. J., Dokras, A., & Piltonen, T. (2026). Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: A multistep global consensus process. The Lancet, 407(10545), 2329–2339.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00717-8/fulltext
World Health Organisation. (2026). Polycystic ovary syndrome. World Health Organisation. https://www.who.int/news-room/fact-sheets/detail/polycystic-ovary-syndrome
Ganie, M. A., Chowdhury, S., Malhotra, N., Sahay, R., Bhattacharya, P. K., Agrawal, S., Jabbar, P. K., Suri, V., Rozati, R., Sreenivas, V., Baba, M. S., Wani, I. A., Rashid, H., Nair, A., Shukla, A., Arora, T., & Kulkarni, B. (2024). Prevalence, phenotypes, and comorbidities of polycystic ovary syndrome among Indian women. JAMA Network Open, 7(10), e2440583. https://pmc.ncbi.nlm.nih.gov/articles/PMC11581580
Zhao, H., Zhang, J., Cheng, X., Nie, X., & He, B. (2023). Insulin resistance in polycystic ovary syndrome across various tissues: An updated review of pathogenesis, evaluation, and treatment. Journal of Ovarian Research, 16, 9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832677/
